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Only a small proportion of genetic variation in complex traits has been explained by SNPs from genome-wide association studies
(GWASs). We report the results from two GWASs for serum markers of iron status (serum iron, serum transferrin, transferrin
saturation with iron, and serum ferritin), which are important in iron overload (e.g., hemochromatosis) and deﬁciency (e.g., anemia)
conditions. We performed two GWASs on samples of Australians of European descent. In the ﬁrst GWAS, 411 adolescent twins and their
siblings were genotyped with 100K SNPs. rs1830084, 10.8 kb 30 of TF, was signiﬁcantly associated with serum transferrin (p total asso-
ciation test¼ 1.03 109; p within-family test¼ 2.23 105). In the second GWAS on an independent sample of 459 femalemonozygotic
(MZ) twin pairs genotyped with 300K SNPs, we found rs3811647 (within intron 11 of TF, HapMap CEU r2 with rs1830084 ¼ 0.86) was
signiﬁcantly associated with serum transferrin (p ¼ 3.0 3 1015). In the second GWAS, we found two additional and independent SNPs
on TF (rs1799852 and rs2280673) and conﬁrmed the known C282Y mutation in HFE to be independently associated with serum trans-
ferrin. The three variants in TF (rs3811647, rs1799852 and rs2280673) plus the HFE C282Y mutation explained ~40% of genetic vari-
ation in serum transferrin (p ¼ 7.8 3 1025). These ﬁndings are potentially important for our understanding of iron metabolism and
of regulation of hepatic protein secretion, and also strongly support the hypothesis that the genetic architecture of some endopheno-
types may be simpler than that of disease.Iron is essential for biochemical functions such as oxygen
transport and oxidative phosphorylation. Excessive iron
can cause iron-overload-related liver diseases (e.g., hemo-
chromatosis [MIM 235200]), whereas iron deﬁciency can
lead to anemia. Iron status can be assessed by measuring
the levels of serum iron, serum transferrin, transferrin sat-
uration with iron, and serum ferritin. Approximately
a quarter to a half of the variation in these iron markers
is due to genetic factors.1,2 The C282Y (a cystine to
tyrosine mutation at position 282) and H63D (a histidine
to aspartate mutation at position 63) mutations in the
hemochromatosis gene (HFE [MIM 235200]) are known
for affecting iron metabolism. These mutations can lead
to genetic hemochromatosis, but they only explain a small
proportion of the heritability of iron status (~5%).1,2
To ﬁnd additional genetic variants associated with varia-
tion in iron status, we ﬁrst conducted a GWAS on 411 in-
dividuals (twins and their sibs) from 150 Australian nuclear
families of European descent using the Affymetrix Gene-
Chip Human Mapping 100K Set, consisting of 50K XbaI
and 50K Hind chips (100K GWAS). Subjects were recruited
by the Genetic Epidemiology Laboratory of the Queens-
land Institute of Medical Research, Australia, as part of
adolescent-twin studies on various phenotypes, including
melanoma risk factors3 and cognition.4 We determined
iron status by measuring the levels of serum iron (mmol/L),
serum transferrin (g/L), and transferrin saturation with
iron (%) and serum ferritin (mg/L) at up to three visits60 The American Journal of Human Genetics 84, 60–65, January 9, 2(age 12, 14, and 16). Because of the skewed distribution,
serum-ferritin levels were transformed (log10) before the
analyses. Methods for phenotypic measurements have
been described elsewhere.2 To remove the need to accom-
modate the correlated nature of the data, we used themean
of the measurements across ages in the association analy-
ses (Table 1 and Table S1 available online). The analysis
on the mean of multiple measures is also more powerful
than analysis that is based on a single measurement and
discarding the others.
Initially, a total of 676 individuals (215 parents and 461
children) from 169 nuclear families were genotyped.
Monozygotic (MZ) twin pairs were present in 64 families
(58 MZ pairs, 4 MZ triplets, and 2 set of triplets containing
an MZ pair). The number of children per family ranged
from two to ﬁve with an average of 2.7. Both parents
were genotyped in 104 families, one parent was genotyped
in seven families, and no parent was genotyped for the
remaining 58 families, but none of them had iron-related
phenotypes measured. The expected relationships be-
tween members of a family were conﬁrmed through the
use of identity by state (IBS) statistics across all SNPs.
A total of 116,204 SNPs from the Affymetrix GeneChip
Human Mapping 100K Set were genotyped in the sample.
Nonautosomal SNPs were removed. Any discordant geno-
types between MZ pairs were also removed. Parent-off-
spring genotype consistency was only checked for the
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chip. Genotypes for all family members were removed in
the case of a mismatch. After these removals, there were
113,199 SNPs. From these SNPs, we further removed
3,876 monomorphic SNPs, 1,884 SNPs that failed the
Hardy-Weinberg Equilibrium (HWE) test (using the Men-
del Statistical Package5) at p% 0.001, 6,592 SNPs in which
the minor allele frequency (MAF) was less than 0.01, and
one duplicate SNP. After the cleaning process, there were
100,846 SNPs that were tested for their association with
the phenotypes related to iron status.
We removed 19 families that were ethnic outliers on the
basis of either self-reported ancestry or a multidimensional
scaling (MDS) plot (Figure S1). To avoid disproportionate
contribution to the test statistics from a very small number
of individuals with extreme phenotypes, we also removed
individuals where their residuals after correcting for cova-
riates (sex, age, age2, sex*age, and sex*age2) were more
than54 SD from the mean (i.e., one individual for trans-
ferrin saturation, two individuals for serum ferritin, and
none for serum iron and serum transferrin) for any given
phenotype. The ﬁnal data consisted of 411 phenotyped
individuals (twins and their siblings) from 150 nuclear
families. The means of the standardized residuals after
covariate correction were used for the analyses.
Family-based genome-wide association analyses were
performed in QTDT,6 where both total and within family
association tests were performed with an additive model.
Both tests use variance components to model the pheno-
typic similarities between related individuals. Although
the within-family association test is robust to population
stratiﬁcation, its power is limited compared to the total
association test because it only uses information from indi-
viduals with heterozygous parents. The model included
an additive genetic effect for the SNP, a polygenic effect, an
environmental effect common to all family members, an
environmental effect common to twins, and a residual
individual-speciﬁc environmental effect.
Table 1. Descriptive Statistics of the Initial Sample from the
100K GWAS
Measure Sex N Min Max Mean SD
Age (years) Male 203 10.05 18.34 14.28 1.6
Female 208 10.22 19.19 14.19 1.77
Total 411 10.05 19.19 14.23 1.68
Serum iron (mmol/L) Male 203 6.65 36 17.54 4.90
Female 206 4.3 33.8 16.99 5.29
Total 409 4.3 36 17.26 5.11
Serum transferrin (g/L) Male 203 2.25 3.73 2.93 0.33
Female 208 2.01 4.15 2.94 0.37
Total 411 2.01 4.15 2.93 0.35
Transferrin saturation (%) Male 203 8.48 47.64 24.22 6.95
Female 206 5.6 57.34 23.45 7.60
Total 409 5.6 57.34 23.83 7.29
Log10 (serum ferritin) mg/L Male 203 0.76 2.27 1.67 0.21
Female 208 0.7 2.21 1.56 0.26
Total 411 0.7 2.27 1.61 0.24
Note that the values are the mean of measurements at up to three visits.The AThe second GWAS was performed in an independent
sample of 459 female monozygotic (MZ) twin pairs, geno-
typed with 315,887 SNPs from the Illumina Human-
Hap300 (300K GWAS). The subjects were Australian adult
female MZ twin pairs of European descent recruited
through the Australian Twin Registry. They were part of
a GenomEUtwin study7 that used genome-wide analyses
of twin and population cohorts to identify genes in com-
mon diseases. They had a mean of age of 46.71 years and
the descriptive statistics of the ﬁnal data set are presented
in Table 2 and Table S2. The measurements of iron status
have been described elsewhere.2
Initially, there were 477 individuals (one individual from
each MZ pair) genotyped with the Illumina Human-
Hap300 (300K GWAS).We removed 15 individuals because
of low genotyping rate (%0.90). From the MDS plot
(Figure S2), three individuals were identiﬁed to be of mixed
ancestry and thus removed from the analyses. As with the
100K GWAS, for any given phenotype we also removed
individuals in which their residuals after correcting for co-
variates (i.e., age) were more than 54 SD from the mean
(i.e., three, two, and ﬁve individuals for serum iron, serum
transferrin, and transferrin saturation, respectively, and
none for serum ferritin). There were 318,237 SNPs geno-
typed in the 300KGWAS sample. As part of the QC process,
we removed 548 SNPs that failed the HWE test (p% 0.001),
1,605 SNPs with more than 10% missing genotypes, and
291 SNPs with MAF < 0.01. Thus, the ﬁnal number of
twin pairs and SNPs used in the association analyses were
459 and 315,887, respectively.
The MZ phenotypes were ﬁrst adjusted for the effect of
age (i.e., 0.063 mmol/L/year, 0.007 g/L/year, 0.045%/
year, and 0.012/year for serum iron, serum transferrin,
transferrin saturation, and serum ferritin, respectively).
The mean of the standardized residuals for the two mem-
bers of each MZ pair was used for the analyses. The associ-
ation was analyzed in PLINK with an additive genetic
model.8 Visualization and annotation of the GWAS results
were performed in WGAViewer.9
From the ﬁrst (adolescent) GWAS, SNP rs1830084 (MAF
0.36), 10.8 kb 30 of the transferrin gene (TF [MIM
190000]), was themost signiﬁcantly associated SNP with se-
rum transferrin (p total association test ¼ 1.0 3 109; p
within-family test ¼ 2.2 3 105) (Table S3). Each copy of
the A allele of rs1830084 increased serum-transferrin levels
by 0.43 SD of the mean phenotype, or ~0.38 phenotypic
Table 2. Descriptive Statistics of the Second GWAS Sample
from the 300K GWAS
Measure Sex N (pairs) Min Max Mean SD
Age (years) Female 441 30.00 91.00 46.71 12.27
Serum iron (mmol/L) Female 441 4.35 43.70 17.26 5.85
Serum transferrin (g/L) Female 441 1.53 5.30 2.92 0.50
Transferrin saturation (%) Female 439 5.30 72.90 24.15 8.72
Log10 (serum ferritin) mg/L Female 441 0.70 3.05 1.81 0.38
Note that the values are the mean of measurements of the MZ pairs.merican Journal of Human Genetics 84, 60–65, January 9, 2009 61
SD. The effect was not signiﬁcantly different between males
and females (p ¼ 0.23). This SNP explained ~7.7% of varia-
tion in serum transferrin andhad no effect on the other iron
markers. There were no typed SNPs signiﬁcantly associated
with other iron status phenotypes (Figure 1).
SNP rs1830084 (which had shown signiﬁcant results in
the ﬁrst GWAS) was not on the HumanHap300 chip used
for the second GWAS, but two SNPs in high-linkage dis-
equilibrium (LD) with it were, rs3811647 (within intron
11 of TF, HapMap CEU r2 ¼ 0.86) and rs6794945 (20.8 kb
from 30 of TF, HapMap CEU r2 ¼ 0.93), and these SNPs
were signiﬁcantly associated with serum-transferrin con-
centration (p ¼ 3.0 3 1015 and 5.0 3 1015, respectively)
(Figures 1 and 2). These were the top two SNPs based on
their p values (Table S4), and their effects were inseparable
because of their high LD (r2¼ 0.86). rs3811647 was also as-
sociated with transferrin saturation (p ¼ 0.002) and serum
ferritin (p ¼ 0.03), but not with serum iron (p ¼ 0.81). The
effect of rs3811647 on serum transferrin was additive with
each A allele increasing serum transferrin by 0.46 SD of the
MZ mean, or ~0.40 phenotypic SD. This SNP explains 13%
of the variation in MZ means or ~10.3% of serum-transfer-
Figure 1. GWAS Results for Iron Status in the 100K and 300K
Studies
On the x and y axis are chromosome number and log10(p) value,
respectively. Red dots indicate the SNPs that reached genome-wide
significance (p < 0.05) after a Bonferroni correction for multiple
testing.62 The American Journal of Human Genetics 84, 60–65, January 9, 2rin variation in the population. Its effect on the other iron
phenotypes was much smaller (2.1 and 1.1% of the varia-
tion in MZ means for transferrin saturation and serum fer-
ritin) (Table 3).
In addition to SNPs in TF, we also conﬁrmed the associ-
ation2 of the known C282Y mutation in HFE (rs1800562)
with iron status in the 300K GWAS. rs1800562 was associ-
ated with serum iron (p ¼ 3.5 3 1011), serum transferrin
(p ¼ 1.1 3 1010), transferrin saturation (p ¼ 4.3 3 1015),
and serum ferritin (p ¼ 4.5 3 105). rs1800562 explained
9.5%, 9.1%, 13.2%, and 3.7% of the variation in
MZ means of serum-iron, serum-transferrin, transferrin-
saturation, and serum-ferritin levels, respectively (Table 3).
The C282Y mutation (rs1800562) was not part of
the 100K Affymetrix GeneChip, and there was no proxy
for it. The other HFE mutation, i.e., H63D mutation
(rs1799945) was neither on 100K nor 300K chips, and
there was no proxy for it. Therefore, we could not deter-
mine the effect of either C282Y or H63D mutations in
the 100K GWAS and could not redetermine the contribu-
tion of the H63D mutation to the variation in iron status
in the 300K GWAS.
Recently, Finberg et al.10 demonstrated that iron-
deﬁciency anemia refractory to oral iron therapy can be
caused bymutations in the transmembrane protease, serine
6 gene (TMPRSS6 [MIM 609862]). This gene codes for
a transmembrane serine protease, which has a role in detect-
ing iron deﬁciency and regulating hepcidin expression.11 In
our 300K GWAS, several SNPs within this gene were associ-
ated with serum-iron levels and transferrin saturation (Table
S5); in particular, a synonymous coding SNP in exon 13
(rs4820268, p ¼ 3.7 3 106 and 2.0 3 105, respectively).
In the 300K GWAS, there were 16 additional SNPs within
60 kb of TF associatedwith serum transferrin at nominal p<
0.05 (Table S6). To determine whether there are multiple
SNPs in this region contributing to variation in serum trans-
ferrin, we ﬁtted a stepwise multiple regression including
those SNPs (excluding rs6794945, which is highly corre-
lated with rs3811647 [HapMap CEU r2 ¼ 0.86]) together
with theHFEC282Ymutation. As a result, we found two ad-
ditional SNPs (in addition to rs3811647), rs1799852 (MAF
0.09), and rs2280673 (MAF 0.34), which were indepen-
dently inﬂuencing variation in serum transferrin (nominal
p¼ 4.73 106 and 2.33 104, respectively). These SNPs ex-
plained an additional 2.2% and 1.7% of variation in MZ
mean of serum transferrin. These estimates are likely to be
biased upward by multiple testing, but the ascertainment
(2 out of 16) was not strong and signiﬁcance was high, so
the bias is likely to be small. rs1799852 and rs2280673
were also associated with serum ferritin (p ¼ 0.04 and
0.003) but not with serum iron or transferrin saturation.
Genetic variants within TF have previously been studied
for their association with iron status,12–16 but to our
knowledge the associations between SNPs rs3811647,
rs1799852, and rs2280673 with serum transferrin levels
have not been reported elsewhere. In addition, the main
TF SNP, rs3811647, is not only common in our samples009
but also in other human populations. A MAF of 0.36, 0.36,
0.52, and 0.23 were reported in the four HapMap popula-
tions (CEU, CHB, JPT, and YRI, respectively). The C282Y
mutation is only polymorphic in the CEU population
with a MAF of 0.04.17
The reported associations in these studies were robust to
population stratiﬁcation. In the 100K GWAS, the within-
Figure 2. The Plots of log10(P) for
the Associations between SNPs in TF 5
60 kb and Serum-Transferrin Levels in
100K and 300K GWAS
The linkage disequilibrium (LD) plot for the
SNPs in the region from the HapMap CEU
population is shown in r2.
family test of the association removed
the effect of population stratiﬁcation
because it tested the alleles that were
transmitted from the parents to their
offspring. In addition, lambda values18
of 1.001, 0.999, 1.009, and 1.003 for
the total association tests of serum
iron, serum transferrin, transferrin sat-
uration, and serum ferritin as well as Q-
Q plots indicated that the residual pop-
ulation-stratiﬁcation effects were very
small or absent (Figure S3). The corre-
sponding lambda values for the 300K
GWAS of 1.004, 1.003, 1.015, and
1.001 and Q-Q plots also indicated
that the effect of population stratiﬁca-
tion on this sample was minimal
(Figure S4).
Both GWAS analyses were per-
formed on the mean of a number of
observations. In the 100K GWAS, the
mean was over repeated observations
per individual, varying from one to
three (Table 1 and Table S1). In the
300K GWAS, the mean was from ob-
servations on pairs of monozygotic twins (Table 2 and Ta-
ble S2). In general, the variance of the mean of n observa-
tions is [(1  r)/n þ r]var(y), with r representing the
intraclass correlation and var(y) representing the variance
in the population. For obtaining the estimated effect size
and the proportion of variance explained in the popula-
tion, the estimates from the means should therefore beTable 3. Additive Effects5 SE of Significant SNPs on Iron Status in Female MZ Twins in the 300K GWAS
Gene SNP
Serum Iron Serum Transferrin Transferrin Saturation Serum Ferritin
Effect in SD R2 p Effect in SD R2 p Effect in SD R2 p Effect in SD R2 p
TF rs3811647 0.015 0.06 0.00 0.81 0.46 5 0.06 0.13 3.0 3
1015
0.175 0.06 0.02 2.1 3
103
0.135 0.06 0.01 0.03
TF rs1799852 0.035 0.09 0.00 0.71 0.435 0.09 0.05 4.7 3
106
0.175 0.09 0.01 0.06 0.20 5 0.10 0.01 0.04
TF rs2280673 0.015 0.06 0.00 0.84 0.22 5 0.06 0.03 2.3 3
104
0.045 0.05 0.00 0.42 0.185 0.06 0.02 2.5 3
103
HFE rs1800562 0.665 0.10 0.10 3.5 3
1011
0.685 0.10 0.09 1.1 3
1010
0.805 0.10 0.13 4.3 3
1015
0.445 .11 0.04 4.5 3
105
TMPRSS6 rs4820268 0.245 0.05 0.05 3.7 3
106
0.015 0.06 0.00 0.87 0.225 0.05 0.04 1.96 3
105
0.015 0.06 0.00 0.80
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scaled with the ratio of the standard deviations of the
mean phenotype and individual phenotypes (Tables S1
and S2). Similarly, the proportion of phenotypic variance
explained in the population is [(1  r)/n þ r] multiplied
by the proportion of variance of the mean phenotypes ex-
plained by a SNP. For example, the mean of serum transfer-
rin in 300K GWAS was based on n ¼ 2 and r ~0.56, so that
the variance of the means is ~0.78 of the variance in the
population. Therefore, the proportion of phenotypic vari-
ance explained in the population is 0.78 of the proportion
of variance in the mean phenotype. The effect size in phe-
notypic standard deviations is O0.78 ~0.88 of the effect size
expressed in standard deviations of the mean phenotype.
From a database of gene expression,19 we found that two
SNPs that signiﬁcantly affected serum-transferrin concen-
tration within TF in the 300K GWAS (i.e., rs1358024 and
rs1115219, HapMap CEU r2 with rs3811647 is 0.38 and
0.18, respectively) were also signiﬁcantly associated with
the level of mRNA expression of the signal-recognition
particle receptor, B subunit gene (SRPRB) (p ¼ 3.5 3
1010 and 1.9 3 108, respectively). This gene is 27 kb dis-
tant from TF and encodes the signal-recognition particle
receptor that is required for targeting of secreted proteins20
(e.g., serum transferrin). We also identiﬁed a SNP in SRPRB
(rs10512913, HapMap CEU r2 with rs3811647 is 0.18) that
was associated with both our serum-transferrin concentra-
tion and the expression of SRPRB mRNA (p ¼ 2.0 3 105
and 2.1 3 108, respectively) (Tables S6 and S7). These ob-
servations are consistent with a possible causative relation-
ship between SRPRB-transcript variation and serum-trans-
ferrin concentration.
The presented statistical signiﬁcances and the estimated
effect sizes should be viewed in terms of the complexity of
the present study. First, all presented p values were unad-
justed for multiple comparison. For the 100K GWAS, the
reference p values after Bonferroni correction that corre-
spond to global signiﬁcance at 5% and 1% were 5 3 107
and 107, respectively. The corresponding p values for
the 300K GWAS were 1.6 3 107 and 3.2 3 108, respec-
tively. Second, the estimated proportions of genetic vari-
ance explained by SNPs were based on the assumption
that the estimated proportion of phenotypic variance
and heritability were accurate.
The samples used in this study were adolescent twins and
their siblings (the 100K GWAS) and adult female MZ twins
(the 300K GWAS). There were a number of issues that were
related to these samples and that are worth discussion.
First, the generalization of the results from samples of twins
may not be applicable to the general population. However,
to our knowledge there is no evidence to suggest that there
are phenotypic differences in the relevant age groups be-
tween twins and nontwins in relation to serum markers
of iron status. Second, the subjects who participated in
this study were volunteers and may not be a random sam-
ple from the population. However, it is difﬁcult to see how
this type of participation bias will have effects on the asso-
ciation between SNPs and phenotypes such as serum64 The American Journal of Human Genetics 84, 60–65, January 9, 2markers of iron status. Third, the association between the
genetic variant in TF (rs1830084 or rs3811647) and serum
transferrin was evident in two samples with different age
ranges. This indicated that the SNPs were associated with
serum transferrin in both adolescent and adult samples.
Variations in serummarkers for iron status are known to
be inﬂuenced by the time of the day when the blood was
collected (particularly for serum iron)2 andmenopausal sta-
tus (particularly for serum ferritin).21 In the 100K GWAS,
the subjects were adolescents and their bloods were col-
lected at approximately the same time of the day for all sub-
jects. However, in the 300K GWAS, the bloods were col-
lected differently throughout the day and some subjects
had reached menopause. To check whether the effects of
SNPs on the serummarkers of iron status were confounded
by the effect of the collection time and menopausal status,
we performed additional association analyses in the 300K
GWAS by adjusting for the effects of the collection time
and menopausal status. The correlations between
log10(p) of the association tests by including and exclud-
ing the collection time andmenopausal status as covariates
were very high (range: 0.89–0.99) (Figure S5). Importantly,
this adjustment did not have any effect on the top hits (top
right-hand corners in Figure S5). Hence, the results pre-
sented were not confounded by the effects of the collection
time and menopausal status.
Overall, the genetic variants identiﬁed in 300K GWAS
(three SNPs in TF [rs3811647, rs1799852, and rs2280673]
and the C282Y mutation in HFE) explained 26% of the
serum-transferrin level variation between MZ means, or
~20% of the phenotypic variance. Whitﬁeld et al.2 esti-
mated the heritability of serum transferrin for women to
be 0.49. Therefore, ~40% of the genetic variation in serum
transferrin in the population can be explained by only
a handful of genetic variants in two genes. This ﬁnding is
remarkably different from that reported for other disease
and quantitative traits.22,23 All signiﬁcant TF SNPs had
pleiotropic effects on serum ferritin, but only rs3811647
had a pleiotropic effect on transferrin saturation. The
pleiotropic effects of the TF SNPs on serum iron were not
statistically signiﬁcant. In addition, we have replicated re-
sults showing that the C282Ymutation inHFE has a signif-
icant effect on iron status and provide evidence that com-
mon variation in TMPRSS6 is associated with serum iron
and transferrin saturation. Our results are important for
understanding of iron metabolism and iron-related disor-
ders, such as anemia and iron overload. Because a large
proportion of genetic variation in serum-transferrin levels
can be explained by only a handful of SNPs at two loci, this
is an example of a relatively simple genetic architecture of
an endophenotype. GWASs on such traits may be more
efﬁcient and effective than GWASs for disease.
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